1. Home
  2. CDIO vs GRFX Comparison

CDIO vs GRFX Comparison

Compare CDIO & GRFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CDIO
  • GRFX
  • Stock Information
  • Founded
  • CDIO 2017
  • GRFX 1981
  • Country
  • CDIO United States
  • GRFX Hong Kong
  • Employees
  • CDIO N/A
  • GRFX N/A
  • Industry
  • CDIO Biotechnology: Commercial Physical & Biological Resarch
  • GRFX
  • Sector
  • CDIO Health Care
  • GRFX
  • Exchange
  • CDIO Nasdaq
  • GRFX Nasdaq
  • Market Cap
  • CDIO 12.3M
  • GRFX 11.9M
  • IPO Year
  • CDIO N/A
  • GRFX N/A
  • Fundamental
  • Price
  • CDIO $0.90
  • GRFX $0.23
  • Analyst Decision
  • CDIO Buy
  • GRFX
  • Analyst Count
  • CDIO 1
  • GRFX 0
  • Target Price
  • CDIO $2.00
  • GRFX N/A
  • AVG Volume (30 Days)
  • CDIO 12.3M
  • GRFX 154.4K
  • Earning Date
  • CDIO 11-13-2024
  • GRFX 01-01-0001
  • Dividend Yield
  • CDIO N/A
  • GRFX N/A
  • EPS Growth
  • CDIO N/A
  • GRFX N/A
  • EPS
  • CDIO N/A
  • GRFX N/A
  • Revenue
  • CDIO $35,688.00
  • GRFX $30,019,108.00
  • Revenue This Year
  • CDIO $2,093.61
  • GRFX N/A
  • Revenue Next Year
  • CDIO $43.05
  • GRFX N/A
  • P/E Ratio
  • CDIO N/A
  • GRFX N/A
  • Revenue Growth
  • CDIO 180.90
  • GRFX N/A
  • 52 Week Low
  • CDIO $0.19
  • GRFX $0.14
  • 52 Week High
  • CDIO $3.56
  • GRFX $1.00
  • Technical
  • Relative Strength Index (RSI)
  • CDIO 58.19
  • GRFX 43.75
  • Support Level
  • CDIO $0.99
  • GRFX $0.18
  • Resistance Level
  • CDIO $1.77
  • GRFX $0.21
  • Average True Range (ATR)
  • CDIO 0.27
  • GRFX 0.02
  • MACD
  • CDIO 0.04
  • GRFX -0.00
  • Stochastic Oscillator
  • CDIO 41.73
  • GRFX 19.82

About CDIO Cardio Diagnostics Holdings Inc. Common stock

Cardio Diagnostics Holdings Inc is a biotechnology company that makes cardiovascular disease prevention and early detection more accessible, personalized, and precise. The company was formed to further develop and commercialize a proprietary artificial intelligence-driven integrated Genetic-Epigenetic EngineTM for cardiovascular disease to become the leading medical technology company for enabling improved prevention, early detection, and assistance in the treatment of cardiovascular disease.

About GRFX Graphex Group Limited each representing 20

Graphex Group Ltd is engaged in the sale of graphene products. It operates in three segments namely, the Graphene Products Segment includes Processing and sale of graphite and graphene-related products; the Landscape Architecture Design Segment includes Providing landscape architecture design; and the catering business focuses on the operation of restaurants. The company derives the majority of its revenue from the sale of graphene products segment.

Share on Social Networks: